Systematic review and meta-analysis of balloon angioplasty versus primary stenting in the infrapopliteal disease

Vascular and Endovascular Surgery

Volumn 48, Issue 1, 2014, Pages 18-26

  Yang, Xinrui ^a   Lu, Xinwu ^a   Ye, Kaichuang ^a   Li, Xiangxiang ^a   Qin, Jinbao ^a   Jiang, Mier ^a  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

Author keywords

balloon angioplasty; infrapopliteal disease; meta analysis; stent; systematic review

Indexed keywords

ACETYLSALICYLIC ACID; CILOSTAZOL; CLOPIDOGREL; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

ARTERY PERFORATION; BARE METAL STENT; BLEEDING; DRUG ELUTING STENT; EXTRAVASATION; FALSE ANEURYSM; HEMATOMA; HUMAN; INFRAPOPLITEAL ARTERY DISEASE; INTERMITTENT CLAUDICATION; LIMB SALVAGE; META ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; REVASCULARIZATION; REVIEW; STENT; SYSTEMATIC REVIEW; THROMBOSIS; ADVERSE EFFECTS; CHI SQUARE DISTRIBUTION; DEVICES; MALE; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME; VASCULAR PATENCY;

ANGIOPLASTY, BALLOON; CHI-SQUARE DISTRIBUTION; HUMANS; LIMB SALVAGE; MALE; PERIPHERAL ARTERIAL DISEASE; POPLITEAL ARTERY; RISK ASSESSMENT; RISK FACTORS; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 84890914653     PISSN: 15385744     EISSN: 19389116     Source Type: Journal    
DOI: 10.1177/1538574413510626     Document Type: Review

References (34)

1. Karnabatidis D, Katsanos K, Siablis D. Infrapopliteal stents: overview and unresolved issues. J Endovasc Ther. 2009 ; 16 (suppl 1). 1153-1162
2. Feiring AJ, Krahn M, Nelson L, Wesolowski A, Eastwood D, Szabo A. Preventing leg amputations in critical limb ischemia with below-the-knee drug-eluting stents: the PaRADISE (PReventing Amputations using Drug eluting StEnts) trial. J Am Coll Cardiol. 2010 ; 55 (15). 1580-1589
3. Bosiers M, Lioupis C, Deloose K, Verbist J, Peeters P. Two-year outcome after Xpert stent implantation for treating below the knee lesions in critical limb ischemia. Vascular. 2009 ; 17 (1). 1-8
4. Diehm N, Baumgartner I, Jaff M, et al. A call for uniform reporting standards in studies assessing endovascular treatment for chronic ischaemia of lower limb arteries. Eur Heart J. 2007 ; 28 (7). 798-805
5. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009 ; 151 (4). 264-269
6. HigginsJPTGreenS, eds. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1.0). The Cochrane Collaboration. http://handbook. cochrane.org/. Accessed March 2011.
7. Met R, Van Lienden KP, Koelemay MJ, Bipat S, Legemate DA, Reekers JA. Subintimal angioplasty for peripheral arterial occlusive disease: a systematic review. Cardiovasc Intervent Radiol. 2008 ; 31 (4). 687-697
8. Fossaceca R, Guzzardi G, Cerini P, et al. Endovascular treatment of diabetic foot in a selected population of patients with below-the-knee disease: is the angiosome model effective?. Cardiovasc Intervent Radiol. 2013 ; 36 (3). 637-644
9. Sigala F, Kontis E, Hepp W, Filis K, Melissas J, Mirilas P. Long-term outcomes following 282 consecutive cases of infrapopliteal PTA and association of risk factors with primary patency and limb salvage. Vasc Endovascular Surg. 2012 ; 46 (2). 123-130
10. Iida O, Soga Y, Hirano K, et al. Midterm outcomes and risk stratification after endovascular therapy for patients with critical limb ischaemia due to isolated below-the-knee lesions. Eur J Vasc Endovasc Surg. 2012 ; 43 (3). 313-321
11. Ryu HM, Kim JS, Ko YG, Hong MK, Jang Y, Choi D. Clinical outcomes of infrapopliteal angioplasty in patients with critical limb ischemia. Korean Circ J. 2012 ; 42 (4). 259-265
12. Kawarada O, Fujihara M, Higashimori A, Yokoi Y, Honda Y, Fitzgerald PJ. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. 2012 ; 80 (5). 861-871
13. Peregrin JH, Koznar B, Kovác J, et al. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol. 2010 ; 33 (4). 720-725
14. Ferraresi R, Centola M, Ferlini M, et al. Long-term outcomes after angioplasty of isolated, below-the-knee arteries in diabetic patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2009 ; 37 (3). 336-342
15. Giles KA, Pomposelli FB, Spence TL, et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg. 2008 ; 48 (1). 128-136
16. Rocha-Singh KJ, Jaff M, Joye J, et al. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial. Catheter Cardiovasc Interv. 2012 ; 80 (6). 1042-1051
17. Dorros G, Jaff MR, Dorros AM, Mathiak LM, He T. Tibioperoneal (outflow lesion) angioplasty can be used as primary treatment in 235 patients with critical limb ischemia: five-year follow-up. Circulation. 2001 ; 104 (17). 2057-2062
18. Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol. 2012 ; 60 (22). 2290-2295
19. Bosiers M, Scheinert D, Peeters P, et al. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg. 2012 ; 55 (2). 390-399
20. Rastan A, Tepe G, Krankenberg H, et al. Sirolimus-eluting stents vs. bare-metal stents for treatment of focal lesions in infrapopliteal arteries: a double-blind, multi-centre, randomized clinical trial. Eur Heart J. 2011 ; 32 (18). 2274-2281
21. Danielsson G, Albrechtsson U, Norgren L, et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg. 2001 ; 21 (5). 432-436
22. Falkowski A, Poncyljusz W, Wilk G, Szczerbo-Trojanowska M. The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol. 2009 ; 19 (4). 966-974
23. Dorros G, Hall P, Prince C. Successful limb salvage after recanalization of an occluded infrapopliteal artery utilizing a balloon expandable (Palmaz-Schatz) stent. Cathet Cardiovasc Diagn. 1993 ; 28 (1). 83-88
24. Katsanos K, Spiliopoulos S, Diamantopoulos A, Karnabatidis D, Sabharwal T, Siablis D. A systematic review of infrapopliteal drug-eluting stents: a meta-analysis of randomized controlled trials. Cardiovasc Intervent Radiol. 2013 ; 36 (3). 645-658
25. Antoniou GA, Chalmers N, Kanesalingham K, et al. Meta-analysis of outcomes of endovascular treatment of infrapopliteal occlusive disease with drug-eluting stents. J Endovasc Ther. 2013 ; 20 (2). 131-144
26. Albers M, Romiti M, Brochado-Neto FC, De Luccia N, Pereira CA. Meta-analysis of popliteal-to-distal vein bypass grafts for critical ischemia. J Vasc Surg. 2006 ; 43 (3). 498-503
27. Falkowski A, Poncyljusz W, Wilk G, Szczerbo-Trojanowska M. The evaluation of primary stenting of sirolimus-eluting versus bare-metal stents in the treatment of atherosclerotic lesions of crural arteries. Eur Radiol. 2009 ; 19 (4). 966-974
28. Bernstein O, Chalmers N. New treatments for infrapopliteal disease: devices, techniques, and outcomes so far. Cardiovasc Intervent Radiol. 2012 ; 35 (4). 715-724
29. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007 ; 33 (suppl 1). S1 - S75
30. Scott NA. Restenosis following implantation of bare metal coronary stents: pathophysiology and pathways involved in the vascular response to injury. Adv Drug Deliv Rev. 2006 ; 58 (3). 358-376
31. Bangalore S, Kumar S, Fusaro M, et al. Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117762 patient-years of follow-up from randomized trials. Circulation. 2012 ; 125 (23). 2873-2891
32. Morice MC, Serruys PW, Barragan P, et al. Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial. J Am Coll Cardiol. 2007 ; 50 (14). 1299-1304
33. Katsanos K, Spiliopoulos S, Krokidis M, Karnabatidis D, Siablis D. Does below-the-knee placement of drug-eluting stents improve clinical outcomes?. J Cardiovasc Surg (Torino). 2012 ; 53 (2). 195-203
34. Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting Balloons in infrapopliteal Arteries. J Am Coll Cardiol. 2011 ; 58 (11). 1105-1109